The blood-brain barrier acts as a gatekeeper restricting what can and cannot reach the brain. Researchers are now designing the next generation of antibody treatments to cross the blood-brain barrier more effectively.

Professor Fiona Carragher, Chief Policy and Research Officer at Alzheimer’s Society, comments on the Chancellor's Autumn Budget:

A new study, funded by Alzheimer’s Society, has identified three existing medications that could be repurposed to treat or prevent Alzheimer’s disease. 

Researchers are studying whether existing, safe medicines could be adapted to treat dementia. This is known as drug repurposing, and it offers fresh hope for finding effective dementia treatments sooner.

Learn more about our new CEO, who brings almost 27 years of experience from working in the Civil Service.

University College London has published a study, part funded by Alzheimer’s Society’s Heather Corrie Impact Fund, which shows it’s possible to cut the time for diagnostic MRI scans for dementia to one third of their standard length.